EQUITY COMPENSATION PROGRAM AND STOCK-BASED COMPENSATION (Tables)

3 Months Ended

Mar. 31, 2024

EQUITY COMPENSATION PROGRAM AND STOCK-BASED COMPENSATION

Schedule of stock-based compensation included in cost of sales and selling, general and administrative expense

	Three Months Ended
	March 31,
	2024		2023
Cost of sales	$	3,851	$	3,243
Selling, general and administrative		24,441		30,960
Total stock-based compensation expense	$	28,292	$	34,203

Schedule of fair value of stock option grants

	Three Months Ended
	March 31,
	2023
Expected Dividend yield	—	%
Expected Volatility	92	%
Risk-free interest rate	0.86	%
Expected term	10 years

Schedule of company's outstanding stock options

		Weighted		Weighted
		Average		Average
		Exercise		Remaining	Aggregate
	Number of	Price per		Contractual	Intrinsic
Stock Options	Options	Option		Term (years)	Value
Outstanding January 1, 2024	1,112,667	$	0.75	6.88	$	1,214,875
Granted	—		—
Exercised	(20,000)		0.27
Expired/Forfeited	—		—
Outstanding March 31, 2024	1,092,667	$	0.75	6.91	$	829,290
Exercisable at March 31, 2024	1,015,991	$	0.72	6.57	$	786,748

Schedule of non-vested stock options granted, vested, and forfeited

	Weighted-average
	Grant-date Fair Value
	Options	($)
Non-Vested - January 1, 2024	206,675	0.89
Granted	—	—
Vested	(130,001)	0.87
Forfeited	—	—
Non-Vested - March 31, 2024	76,674	1.16